Demonstrates complex signaling changes in prostate cancer cells following CAPE treatment, suggesting new avenues for cancer treatment.
(1) Background: Caffeic acid phenethyl ester (CAPE) exhibits anticancer activity; however, its time-dependent effects on interconnected signalling pathways remain incompletely characterised. (2) Methods: We combined wet-lab experiments (MTT viability assay and ELISA measurements of total NF−κB p65 and p53) with a Bayesian digital twin framework to quantify signalling dynamics in prostate cancer cells following CAPE exposure. p53-deficient PC3 and p53-competent LNCaP cell lines were treated for 24 h and 48 h across multiple CAPE concentrations. Experimental data were integrated into a mechanistic Bayesian model using robust likelihoods, enabling uncertainty-aware parameter inference and posterior predictive validation via leave-one-dose-out analysis. (3) Results: In PC3 cells, CAPE induced dose-dependent inhibition of NF−κB p65 that was consistently associated with reduced cell viability at both time points, consistent with a p53-independent regulatory regime. In contrast, LNCaP cells exhibited a transient NF−κB–p53 coupling at 24 h, characterised by delayed NF−κB suppression and pronounced p53 activation, followed by a more stable and weakly coupled signalling state at 48 h. These temporal patterns were supported by posterior parameter estimates and predictive performance under leave-one-dose-out validation. (4) Conclusions: This study demonstrates that Bayesian digital twins enable quantitative, uncertainty-aware analysis of time-dependent drug responses, extending beyond conventional dose–response assessments and supporting mechanistic hypothesis generation in cancer pharmacology.
No takes yet. Share an insight, caveat, or question.
Dzik et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: